{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:20:29Z","timestamp":1783070429658,"version":"3.54.6"},"reference-count":35,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T00:00:00Z","timestamp":1339027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Serum hepcidin concentration is potentially affected by inflammation and iron stores in chronic liver disease (<jats:styled-content style=\"fixed-case\">CLD<\/jats:styled-content>), but little is known about the relationship between hepcidin and the degree of hepatic fibrosis. We investigated the potential role of serum hepcidin as a biomarker of advanced liver disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum hepcidin was measured in 332 adults with <jats:styled-content style=\"fixed-case\">CLD<\/jats:styled-content> of varying aetiologies, 45 healthy and 50 non\u2010liver disease patient controls. Liver biopsy data were available for 228 <jats:styled-content style=\"fixed-case\">CLD<\/jats:styled-content> subjects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Hepcidin was decreased in <jats:styled-content style=\"fixed-case\">CLD<\/jats:styled-content> patients compared with non\u2010liver disease patient controls (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.0001) but not healthy controls, and was lowest in those with cirrhosis (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.0001). Serum hepcidin correlated with hepatic hepcidin <jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content> expression in 91 biopsy samples available for genetic analysis (<jats:italic>r\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.68, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.0001). Hepcidin also correlated positively with serum ferritin concentration, transferrin saturation, <jats:styled-content style=\"fixed-case\">ALT<\/jats:styled-content>, serum albumin and haemoglobin, but negatively with serum bilirubin. The hepcidin:ferritin ratio was significantly lower in <jats:styled-content style=\"fixed-case\">CLD<\/jats:styled-content> subjects compared with healthy and disease controls, and decreased with each increase in the stage of fibrosis and siderosis. The hepcidin:ferritin ratio was associated with progressive fibrosis on linear regression, and a value of less than 0.1 was independently associated with cirrhosis on logistic regression analyses (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content> 5.54, <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.001). Receiver operating characteristic analysis showed the hepcidin:ferritin ratio was able to distinguish between <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>0 and <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>4 stages of fibrosis (area under receiver operating characteristic curve\u00a0=\u00a00.86).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The hepcidin:ferritin ratio is reduced in relation to increasing fibrosis in <jats:styled-content style=\"fixed-case\">CLD<\/jats:styled-content> and the use of this ratio may have potential future diagnostic implications as a marker of cirrhosis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1478-3231.2012.02828.x","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T04:01:24Z","timestamp":1339128084000},"page":"1391-1399","source":"Crossref","is-referenced-by-count":51,"title":["The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis"],"prefix":"10.1111","volume":"32","author":[{"given":"Terrence C. H.","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology Princess Alexandra Hospital  Brisbane Australia"},{"name":"School of Medicine The University of Queensland  Brisbane Australia"},{"name":"Gallipoli Research Foundation Greenslopes Hospital  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell H. G.","family":"Crawford","sequence":"additional","affiliation":[{"name":"School of Medicine The University of Queensland  Brisbane Australia"},{"name":"Gallipoli Research Foundation Greenslopes Hospital  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Franklin","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Princess Alexandra Hospital  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Jaskowski","sequence":"additional","affiliation":[{"name":"School of Medicine The University of Queensland  Brisbane Australia"},{"name":"Gallipoli Research Foundation Greenslopes Hospital  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme A.","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology Princess Alexandra Hospital  Brisbane Australia"},{"name":"School of Medicine The University of Queensland  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Jonsson","sequence":"additional","affiliation":[{"name":"School of Medicine The University of Queensland  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Watson","sequence":"additional","affiliation":[{"name":"Health Statistics Centre Queensland Health  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Princess Alexandra Hospital  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology Princess Alexandra Hospital  Brisbane Australia"},{"name":"School of Medicine The University of Queensland  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,6,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.538"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104742"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-258467"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg560"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.149187"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002706"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp546"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008922200"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.05.014"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2008.09.004"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(05)80127-1"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23537"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24635"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24706"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-337907"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9041250"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.004"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310227"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36569"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.593"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240201"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02175.x"},{"key":"e_1_2_8_25_1","first-page":"A171","article-title":"A semi\u2010automated method for the measurement of hepcidin in plasma by on\u2010line extraction coupled to liquid chromatography\u2010tandem mass spectrometry","volume":"57","author":"Franklin M","year":"2010","journal-title":"Clin Chem"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2009.00969.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.141"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05990809"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq099"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328343b885"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01244.x"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.06.027"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/met.2010.0121"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.2119\/2006-00057.Fujita"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-923317"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08161109"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2012.02828.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2012.02828.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:35:58Z","timestamp":1695508558000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2012.02828.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,7]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1111\/j.1478-3231.2012.02828.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02828.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,7]]}}}